Other languages Isofol Medical AB

Equities

Delayed Nasdaq Stockholm Other stock markets 12:33:57 29/04/2024 BST			5-day change	1st Jan Change
0.716 ^SEK	+3.17%		-0.42%	-1.92%

02-20	Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
02-20	Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-20
Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-20
Isofol Medical Hires New CFO	01-11
Isofol Medical Names New CEO	01-09
Isofol Medical AB Announces CEO Changes	01-09
Isofol Medical AB Announces Board Elections	01-04
Isofol Medical AB Presents Additional Results from Laboratory Tests with Arfolitixorin Showing Supplementary Effects	12-28
Isofol Medical AB Appoints Jan-Eric Österlund as Member of the Board	12-13
Isofol Receives the First Results from Laboratory Tests of Arfolitixorin	12-07
Isofol Medical Unit to Face Liquidation	12-01
Isofol Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-10
Isofol Receives Shareholders Request for EGM; Shares Fall	11-09
Isofol Medical AB Announces Appointment of Nomination Committee Members	11-08
Isofol Medical AB Announces Results from the Modelle 001 Study	05/10/23
Isofol Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/08/23
Isofol Medical AB Presents Conclusions from the In-Depth Analysis of the AGENT Study	04/07/23
Sweden's Isofol Medical Names Acting CEO	23/06/23
Isofol Medical AB Appoints Roger Tell as Acting CEO	22/06/23
Isofol Medical CEO Steps Down	22/06/23
Isofol Medical AB Announces Resignation of Thomas Andersson as CEO	21/06/23

No results for this search